Back
Acta Physiologica 2007; Volume 191, Supplement 658
Joint Meeting of The Slovak Physiological Society, The Physiological Society and The Federation of European Physiological Societies
9/11/2007-9/14/2007
Bratislava, Slovakia
SUSCEPTIBILITY TO ISCHAEMIA-INDUCED ARRHYTHMIAS AND THE EFFECT OF MITOCHONDRIAL KATP CHANNELS ACTIVATION AND ANTIOXIDANT TREATMENT IN THE DIABETIC RAT HEART
Abstract number: PW03-16
Matejikova1 J., Ondrejcakova1 M., Pancza1 D., Blazickova1 I., Formankova1 I., Ravingerova1 T.
1Institute of Heart Research, Slovak Acad. Sci., Bratislava, Slovakia
Aims:
Opening of mitochondrial KATP channels (mKATP) interacting with free radicals is suggested as a key element in antiischaemic protection in the normal heart, while its role in diabetes mellitus (DM) is unclear. The aims were to characterise ischaemia-induced arrhythmias and effects of N-acetylcysteine (NAC) and mKATP opener diazoxide (D) in the diabetic rat heart.
Methods:
Seven days after streptozotocin injection, Langendorff-perfused hearts were subjected to 30min occlusion of the LAD coronary artery with or without 15min treatment with D (50mM) or NAC (4mM).
Results:
Total number of ventricular premature beats (VPB) was lower in the DM group. Similarly, number of episodes and duration of ventricular tachycardia (VT) were reduced to 6.1 ± 3.7 and 1.8 ± 0.6s (from 12.1 ± 2.4 and 3.4 ± 0.5s, resp., in non-DM controls; P < 0.05). Both, D and NAC were antiarrhythmic in non-DM group. In the diabetics, D further suppressed arrhythmias (VT 0.6 ± 0.4 and 0.4 ± 0.2s; P < 0.05 vs. non-treated DM), while NAC did not modify arrrhythmogenesis (VT 6.2 ± 2.6 and 2.8 ± 1.2s; P > 0.05 vs. non-treated DM).
Conclusions:
Early period of DM is associated with enhanced resistance to ischaemia-induced arrhythmias facilitated by mKATP opening. DM might induce adaptive processes in the myocardium that reduce susceptibility to antioxidant treatment. Grants VEGA SR 2/5110/25, APVT 51-027404.
Groups | VPB (total number) | | |
---|
| C | D | NAC |
Non-diabetic | 538 ± 58 | 168 ± 22* | 290 ± 52* |
Diabetic | 224 ± 53* | 71 ± 24* | 207 ± 51* |
* P < 0.05 vs. non-diabetics controls; P < 0.05 vs. non-treated diabetics |
To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 191, Supplement 658 :PW03-16